African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014

dc.contributor.authorWeyer, Camilla Theresa
dc.contributor.authorGrewar, John Duncan
dc.contributor.authorBurger, Phillipa
dc.contributor.authorRossouw, Esthea
dc.contributor.authorLourens, Carina W.
dc.contributor.authorJoone, Christopher
dc.contributor.authorle Granje, Misha
dc.contributor.authorCoetzee, Peter
dc.contributor.authorVenter, Estelle Hildegard
dc.contributor.authorMartin, Darren P.
dc.contributor.authorMacLachlan, N.J. (James)
dc.contributor.authorGuthrie, Alan John
dc.contributor.emailalan.guthrie@up.ac.zaen_ZA
dc.date.accessioned2017-01-23T08:52:16Z
dc.date.available2017-01-23T08:52:16Z
dc.date.issued2016-12
dc.description.abstractAfrican horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member countries seeking official recognition of disease-free status. Since 1997, South Africa has maintained an AHS controlled area; however, sporadic outbreaks of AHS have occurred in this area. We compared the whole genome sequences of 39 AHS viruses (AHSVs) from field AHS cases to determine the source of 3 such outbreaks. Our analysis confirmed that individual outbreaks were caused by virulent revertants of AHSV type 1 live, attenuated vaccine (LAV) and reassortants with genome segments derived from AHSV types 1, 3, and 4 from a LAV used in South Africa. These findings show that despite effective protection of vaccinated horses, polyvalent LAV may, paradoxically, place susceptible horses at risk for AHS.en_ZA
dc.description.departmentEquine Research Centreen_ZA
dc.description.librarianam2017en_ZA
dc.description.urihttp://www.cdc.gov/eiden_ZA
dc.identifier.citationWeyer, CT, Grewar, JD, Burger, P, Rossouw, E, Lourens, C, Joone, C, Le Grange, M, Coetzee, P, Venter, E, Martin, DP, MacLachlan, NJ & Guthrie, AJ 2016, 'African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014', Emerging Infectious Diseases, vol. 22, no. 12, pp. 2087-2096.en_ZA
dc.identifier.issn1080-6040 (print)
dc.identifier.issn1080-6059 (online)
dc.identifier.other10.3201/eid2212.160718
dc.identifier.urihttp://hdl.handle.net/2263/58599
dc.language.isoenen_ZA
dc.publisherCenters for Disease Control and Preventionen_ZA
dc.rightsCenters for Disease Control and Prevention (CDC)en_ZA
dc.subjectHorsesen_ZA
dc.subjectAfrican horse sickness (AHS)en_ZA
dc.subjectSouth Africa (SA)en_ZA
dc.subjectLive, attenuated vaccine (LAV)en_ZA
dc.subjectAfrican horse sickness virus (AHSV)en_ZA
dc.titleAfrican horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014en_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Weyer_African_2016.pdf
Size:
4.79 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: